[1] Harati Y. Diabetic peripheral neuropathies. Methodist Debakey Cardiovasc J. 2010;6(2):15-19.[2] Gebel E. New hope for ending complications. Working together to protect your body from diabetes damage. Diabetes Forecast. 2012;65(4):56, 59-60.[3] Shiyovich A, Sztarkier I, Nesher L. Toxic hepatitis induced by Gymnema sylvestre, a natural remedy for type 2 diabetes mellitus. Am J Med Sci. 2010;340(6):514-517.[4] Russell-Jones D. The safety and tolerability of GLP-1 receptor agonists in the treatment of type-2 diabetes. Int J Clin Pract. 2010;64(10):1402-1414.[5] Kaewkorn W, Limpeanchob N, Tiyaboonchai W, et al. Effects of silk sericin on the proliferation and apoptosis of colon cancer cells. Biol Res. 2012;45(1):45-50.[6] Nayak S, Talukdar S, Kundu SC. Potential of 2D crosslinked sericin membranes with improved biostability for skin tissue engineering. Cell Tissue Res. 2012;347(3):783-794. [7] Zhaorigetu S, Yanaka N, Sasaki M, et al. Inhibitory effects of silk protein, sericin on UVB-induced acute damage and tumor promotion by reducing oxidative stress in the skin of hairless mouse. J Photochem Photobiol B. 2003;71(1-3): 11-17. [8] Fu XM, Zhong MR, Fu WL, et al. Effects of sericine on blood glucose and blood lipid in type 2 diabetes rats. Zhongguo Laonian Xue Zazhi. 2011;31(1):103-105.[9] Fu XM, Ma HW, Fu WL, et al. Protective effects of sericin on pancreatic islet cells of type II diabetic rat. Jiepou Xue Zazhi. 2010;33(2):161-164. [10] Liu XY, Fu XM, Gao Y, et al. Protective effects of sericin on islet cells apoptosis of type 2 diabetes rats. Zhongguo Laonian Xue Zazhi. 2012;32(12):2525-2527.[11] Fu WL, He YQ, Ma HW, et al. Effects of sericine on proliferation and related factors of germ cells in testis of type 2 diabetic rats. Zhongguo Yike Daxue Xuebao. 2010; 39(5):332-335.[12] Fu WL, Fu XM, Zhong MR, et al. Effects of sericine on growth hormone/insulin-like growth factor-1 axis of testis in type 2 diabetes mellitus rats. Jiepou Xuebao. 2011; 42(1):104-109. [13] Fu WL, Zhong MR, He YQ, et al. Effects of sericine pretreatment on IGF-1 expression in testes of diabetes mellitus rat model. Zhongguo Zuzhi Huaxue yu Xibao Huaxue Zazhi. 2010;19(4):361-364.[14] Diolaiti D, Bernardoni R, Trazzi S, et al. Functional cooperation between TrkA and p75(NTR) accelerates neuronal differentiation by increased transcription of GAP-43 and p21(CIP/WAF) genes via ERK1/2 and AP-1 activities. Exp Cell Res. 2007;313(14):2980-2992. [15] Renton JP, Xu N, Clark JJ, et al. Interaction of neurotrophin signaling with Bcl-2 localized to the mitochondria and endoplasmic reticulum on spiral ganglion neuron survival and neurite growth. J Neurosci Res. 2010;88(10):2239-2251. [16] Nässel DR, Wegener C. A comparative review of short and long neuropeptide F signaling in invertebrates: Any similarities to vertebrate neuropeptide Y signaling? Peptides. 2011;32(6):1335-1355. [17] Nguyen AD, Herzog H, Sainsbury A. Neuropeptide Y and peptide YY: important regulators of energy metabolism. Curr Opin Endocrinol Diabetes Obes. 2011;18(1):56-60.[18] Ackerley S, James PA, Kalli A, et al. A mutation in the small heat-shock protein HSPB1 leading to distal hereditary motor neuronopathy disrupts neurofilament assembly and the axonal transport of specific cellular cargoes. Hum Mol Genet. 2006;15(2):347-354. [19] Xu G, Pierson CR, Murakawa Y, et al. Altered tubulin and neurofilament expression and impaired axonal growth in diabetic nerve regeneration. J Neuropathol Exp Neurol. 2002;61(2):164-175.[20] von Wilmowsky C, Stockmann P, Harsch I, et al. Diabetes mellitus negatively affects peri-implant bone formation in the diabetic domestic pig. J Clin Periodontol. 2011;38(8): 771-779. [21] Pierson CR, Zhang W, Sima AA. Proinsulin C-peptide replacement in type 1 diabetic BB/Wor-rats prevents deficits in nerve fiber regeneration. J Neuropathol Exp Neurol. 2003;62(7):765-779.[22] Scott JN, Clark AW, Zochodne DW. Neurofilament and tubulin gene expression in progressive experimental diabetes: failure of synthesis and export by sensory neurons. Brain. 1999;122 ( Pt 11):2109-2118.[23] Li Y, Jung P, Brown A. Axonal transport of neurofilaments: a single population of intermittently moving polymers. J Neurosci. 2012;32(2):746-758.[24] Shea TB, Lee S. Neurofilament phosphorylation regulates axonal transport by an indirect mechanism: a merging of opposing hypotheses. Cytoskeleton (Hoboken). 2011; 68(11):589-595. [25] Kanbayashi H, Itoh H, Kashiwaya T, et al. Spatial distribution of nociceptive neuropeptide and nerve growth factor depletion in experimental diabetic peripheral nervous system. J Int Med Res. 2002;30(5): 512-519.[26] Gezginci-Oktayoglu S, Sacan O, Yanardag R, et al. Exendin-4 improves hepatocyte injury by decreasing proliferation through blocking NGF/TrkA in diabetic mice. Peptides. 2011;32(2):223-231. [27] Castro A, Manso MJ, Anadón R. Distribution of neuropeptide Y immunoreactivity in the central and peripheral nervous systems of amphioxus (Branchiostoma lanceolatum Pallas). J Comp Neurol. 2003;461(3): 350-361.[28] Zhaohui Z, Jingzhu Z, Guipeng D, et al. Role of neuropeptide Y in regulating hypothalamus-pituitary- gonad axis in the rats treated with electro-acupuncture. Neuropeptides. 2012;46(3):133-139. [29] Férézou I, Hill EL, Cauli B, et al. Extensive overlap of mu-opioid and nicotinic sensitivity in cortical interneurons. Cereb Cortex. 2007;17(8):1948-1957. [30] Gonsalvez DG, Kerman IA, McAllen RM, et al. Chemical coding for cardiovascular sympathetic preganglionic neurons in rats. J Neurosci. 2010;30(35):11781-11791.[31] Onuoha GN, Nicholls DP, Alpar EK, et al. Regulatory peptides in the heart and major vessels of man and mammals. Neuropeptides. 1999;33(2):165-172.[32] Baldassano S, Wang GD, Mulè F, et al. Glucagon-like peptide-1 modulates neurally evoked mucosal chloride secretion in guinea pig small intestine in vitro. Am J Physiol Gastrointest Liver Physiol. 2012;302(3): G352-358.[33] Jacques D, Sader S, El-Bizri N, et al. Neuropeptide Y induced increase of cytosolic and nuclear Ca2+ in heart and vascular smooth muscle cells. Can J Physiol Pharmacol. 2000;78(2):162-172.[34] Jacques D, Abdel-Samad D. Neuropeptide Y (NPY) and NPY receptors in the cardiovascular system: implication in the regulation of intracellular calcium. Can J Physiol Pharmacol. 2007;85(1):43-53.[35] The Ministry of Science and Technology of the People’s Republic of China. Guidance Suggestions for the Care and Use of Laboratory Animals. 2006-09-30. [36] Xiang X, Wang Z, Zhu Y, et al. Dosage of streptozocin in inducing rat model of type 2 diabetes mellitus. Wei Sheng Yan Jiu. 2010;39(2):138-142.[37] Li X, Cui X, Sun X, et al. Mangiferin prevents diabetic nephropathy progression in streptozotocin-induced diabetic rats. Phytother Res. 2010;24(6):893-899.[38] Zhan YL, Huang CF, Chen GL. Hypoglycemic activity of the decoction of cocoon shell on alloxan-diabetic model mice. Canye Kexue. 2003;29(4):446-448. [39] Chen ZH, He YQ, Fu WL, et al. Effects of sericin on heme oxygenase-1 expression in the hippocampus and cerebral cortex of type 2 diabetes mellitus rats. Neural Regen Res. 2011;6(6):423-427.[40] Kikuno N, Kawamoto K, Hirata H, et al. Nerve growth factor combined with vascular endothelial growth factor enhances regeneration of bladder acellular matrix graft in spinal cord injury-induced neurogenic rat bladder. BJU Int. 2009;103(10):1424-1428. [41] Chen ZH, He YQ, Song CJ, et al. Sericin can reduce hippocampal neuronal apoptosis by activating the Akt signal transduction pathway in a rat model of diabetes mellitus. Neural Regen Res. 2012;7(3):197-201. |